The integration of artificial intelligence (AI) and machine learning (ML) with digital twins is leading to a revival in discussions about what innovation means and how it should be defined to capture value outcomes for patients. In the context of pharmaceutical medicine, innovation has traditionally been thought of as the development of new and improved …
